TG THERAPEUTICS, INC. (TGTX) Operating income 2016–2025
TG THERAPEUTICS, INC. (TGTX) annual operating income history from SEC filings — each fiscal year as reported.
$123.3MFY2025 · since FY2016: -$79.0M → $123.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $123.3M | +194.1% |
| FY2024 | $41.9M | +103.2% |
| FY2023 | $20.6M | +109.5% |
| FY2022 | -$218.3M | +36.7% |
| FY2021 | -$344.8M | -26.0% |
| FY2020 | -$273.6M | -61.8% |
| FY2019 | -$169.1M | +3.1% |
| FY2018 | -$174.4M | -46.9% |
| FY2017 | -$118.7M | -50.3% |
| FY2016 | -$79.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice